Calandra G - Search Results

1

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.

Miskovsky E, Gershman K, Clements ML, Cupps T, Calandra G, Hesley T, Ioli V, Ellis R, Kniskern P, Miller W, et al. Miskovsky E, et al. Among authors: calandra g. Vaccine. 1991 May;9(5):346-50. doi: 10.1016/0264-410x(91)90062-b. Vaccine. 1991. PMID: 1872019 Clinical Trial.

2

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

Ellerbeck EF, Lewis JA, Nalin D, Gershman K, Miller WJ, Armstrong ME, Davide JP, Rhoad AE, McGuire B, Calandra G, et al. Ellerbeck EF, et al. Among authors: calandra g. Vaccine. 1992;10(10):668-72. doi: 10.1016/0264-410x(92)90087-z. Vaccine. 1992. PMID: 1523877 Free article. Clinical Trial.

3

Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations.

West DJ, Calandra GB, Hesley TM, Ioli V, Miller WJ. West DJ, et al. Among authors: calandra gb. Vaccine. 1993;11 Suppl 1:S21-7. doi: 10.1016/0264-410x(93)90154-p. Vaccine. 1993. PMID: 8447168 Review.

4

Vaccination of infants and children against hepatitis B.

West DJ, Calandra GB, Ellis RW. West DJ, et al. Among authors: calandra gb. Pediatr Clin North Am. 1990 Jun;37(3):585-601. doi: 10.1016/s0031-3955(16)36906-1. Pediatr Clin North Am. 1990. PMID: 2140881 Review.

5

Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.

Midthun K, Ellerbeck E, Gershman K, Calandra G, Krah D, McCaughtry M, Nalin D, Provost P. Midthun K, et al. Among authors: calandra g. J Infect Dis. 1991 Apr;163(4):735-9. doi: 10.1093/infdis/163.4.735. J Infect Dis. 1991. PMID: 1849160 Clinical Trial.

6

Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.

White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB. White CJ, et al. Among authors: calandra gb. Pediatrics. 1991 May;87(5):604-10. Pediatrics. 1991. PMID: 1850506

7

Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age.

Keyserling HL, West DJ, Hesley TM, Bosley C, Wiens BL, Calandra GB. Keyserling HL, et al. Among authors: calandra gb. J Pediatr. 1994 Jul;125(1):67-9. doi: 10.1016/s0022-3476(94)70123-7. J Pediatr. 1994. PMID: 8021788

8

Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky children.

Block SL, Hedrick JA, Tyler RD, Smith RA, Calandra G, Patterson C, Lewis J, Sitrin R, Miller W, Schwartz S, et al. Block SL, et al. Among authors: calandra g. Pediatr Infect Dis J. 1993 Dec;12(12):976-80. doi: 10.1097/00006454-199312000-00002. Pediatr Infect Dis J. 1993. PMID: 8108223 Clinical Trial.

9

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.

Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, et al. Werzberger A, et al. Among authors: calandra g. N Engl J Med. 1992 Aug 13;327(7):453-7. doi: 10.1056/NEJM199208133270702. N Engl J Med. 1992. PMID: 1320740 Free article. Clinical Trial.

10

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination.

West DJ, Calandra GB. West DJ, et al. Among authors: calandra gb. Vaccine. 1996 Aug;14(11):1019-27. doi: 10.1016/0264-410x(96)00062-x. Vaccine. 1996. PMID: 8879096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters